BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23405208)

  • 41. C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
    Kim MH; Minton AZ; Agrawal V
    Prostate; 2009 Sep; 69(13):1435-47. PubMed ID: 19489038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
    Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
    Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence.
    Chen C; Dudenhausen EE; Pan YX; Zhong C; Kilberg MS
    J Biol Chem; 2004 Jul; 279(27):27948-56. PubMed ID: 15102854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surfactant protein D gene regulation. Interactions among the conserved CCAAT/enhancer-binding protein elements.
    He Y; Crouch E
    J Biol Chem; 2002 May; 277(22):19530-7. PubMed ID: 11912209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.
    Tissières P; Araud T; Ochoda A; Drifte G; Dunn-Siegrist I; Pugin J
    J Biol Chem; 2009 Sep; 284(39):26261-72. PubMed ID: 19632992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C/EBPβ regulates P2X7 receptor expression in response to glucose challenge in intestinal epithelial cells.
    Bilodeau MS; Arguin G; Gendron FP
    Biochem Cell Biol; 2015 Feb; 93(1):38-46. PubMed ID: 25403356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C/EBPβ (CCAAT/enhancer-binding protein β) mediates progesterone production through transcriptional regulation in co-operation with SF-1 (steroidogenic factor-1).
    Mizutani T; Ju Y; Imamichi Y; Osaki T; Yazawa T; Kawabe S; Ishikane S; Matsumura T; Kanno M; Kamiki Y; Kimura K; Minamino N; Miyamoto K
    Biochem J; 2014 Jun; 460(3):459-71. PubMed ID: 24635384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
    Fang T; Cui M; Sun J; Ge C; Zhao F; Zhang L; Tian H; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li H; Li J
    Oncotarget; 2015 Jun; 6(18):16106-19. PubMed ID: 25965830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
    Li H; Baldwin BR; Zahnow CA
    Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP.
    Masaki T; Matsuura T; Ohkawa K; Miyamura T; Okazaki I; Watanabe T; Suzuki T
    Biochem J; 2006 Jul; 397(2):345-53. PubMed ID: 16608438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.
    Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G
    Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.
    Cui TX; Piwien-Pilipuk G; Huo JS; Kaplani J; Kwok R; Schwartz J
    Mol Endocrinol; 2005 Aug; 19(8):2175-86. PubMed ID: 15860545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.
    Gunasekharan V; Haché G; Laimins L
    J Virol; 2012 May; 86(9):5393-8. PubMed ID: 22379085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
    Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
    Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle.
    Shimomura Y; Wajid M; Shapiro L; Christiano AM
    Development; 2008 Feb; 135(4):743-53. PubMed ID: 18199584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
    Liu M; Yuan T; Liu H; Chen P
    Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3.
    Zhao X; Zhuang S; Chen Y; Boss GR; Pilz RB
    J Biol Chem; 2005 Sep; 280(38):32683-92. PubMed ID: 16055922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.